Aster Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Aster Capital Management's RMD Position: Q3 2026 in Review
Aster Capital Management reduced its ResMed (RMD) stake by 5.7% in Q3 2026, selling an estimated $54.1K and leaving 4,125 shares worth $912K. The position accounts for 0.33% of the portfolio, ranked #71.
Aster Capital Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Aster Capital Management held 4,125 shares of ResMed worth $912K as of Q3 2026.
- Aster Capital Management sold 248 ResMed shares in Q3 2026, an estimated $54.1K.
- ResMed made up 0.33% of Aster Capital Management's portfolio in Q3 2026, its #71 holding.
- Aster Capital Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
- 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.